Anti-Human CD20 Recombinant Antibody(Ublituximab)
-
产品编号
YR1251
-
别名
科研级 Ublituximab ( 乌妥昔单抗 ), Anti-CD20 Recombinant Antibody, Research Grade Ublituximab
-
规格
- 1mg
- 5mg
| Catalog Number | YR1251 |
| Alias | 科研级 Ublituximab ( 乌妥昔单抗 ), Anti-CD20 Recombinant Antibody, Research Grade Ublituximab |
| Size | 1mg, 5mg |
| Molecular Name | Ublituximab |
| CAS Number | 1174014-05-1 |
| Target | CD20[Homo sapiens] |
| Antibody Isotype | IgG1 Kappa |
| Clonity | Monoclonal |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Formulation | PBS, pH7.5 |
| Shipping Condition | Shipped on ice packs. |
| Background | Ublituximab is an immunomodulator. It binds to CD20. It is in Phase 3 clinical trials for multiple sclerosis. It is also in "U2" Phase 3 clinical trials for chronic lymphocytic leukemia in combination with Umbralisib. |
| Remarks | This product is for research use only. |
0